QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

AVNS

QT66Avanos Medical, Inc.
NYSE·Healthcare·Medical - Devices·USA
Latest market price
24.94
+0.07+0.28%
OverviewShort InterestFilings
AVNSQT66Avanos Medical, Inc.·NYSE
OverviewShort InterestFilings
24.94+0.28%
TA
Loading chart...
Screen all →
ABT-0.10%$88.41ISRG+1.14%$406.78SYK+2.21%$307.80MDT+1.54%$79.34BSX+0.76%$45.29EW+0.78%$87.36DXCM+1.74%$72.47RMD+1.26%$188.63
Snapshot
Index-P/E-EPS (ttm)-1.50
Insider Own-
Shs Outstand-
Perf Week-0.16%
Market Cap1.17BForward P/E19.95EPS next Y1.25Insider Trans-Shs Float-Perf Month0.77%
Enterprise Value1.24BPEG-EPS next Q0.16Inst Own-Short Float-Perf Quarter85.29%
Income-70022798.00P/S1.63EPS this Y166.67%Inst Trans-Short Ratio-Perf Half Y114.63%
Sales715.88MP/B1.48EPS next Y25.00%ROA-6.61%Short Interest-Perf YTD122.08%
Book/sh-P/C31.44EPS next 5Y25.00%ROE-8.91%52W High25.49 -2.16%Perf Year105.44%
Cash/sh-P/FCF155.35EPS past 3/5Y-ROIC-6.03%52W Low9.30 168.17%Perf 3Y-
Dividend Est.-EV/EBITDA-57.31Sales past 3/5Y0.82% -0.39%Gross Margin48.55%Volatility0.19% 0.48%Perf 5Y-
Dividend TTM-EV/Sales1.73EPS Y/Y TTM110.55%Oper. Margin-7.92%ATR (14)0.14Perf 10Y-
Dividend Ex-Date-Quick Ratio1.40Sales Y/Y TTM4.07%Profit Margin-9.69%RSI (14)70.88Recom3.00
Dividend Gr. 3/5Y-Current Ratio2.48EPS Q/Q-15.38%SMA200.13%Beta1.35Target Price23.00
Payout0.00%Debt/Eq0.18Sales Q/Q8.33%SMA503.26%Rel Volume1.63Prev Close24.87
Employees2,227LT Debt/Eq0.14EarningsAug 04SMA20062.30%Avg Volume1.84MPrice24.94
IPO DateOct 21, 2014Option/ShortYes / YesEPS/Sales Surpr.37.50% 7.06%Net Debt/EBITDA-3.37Volume2,998,069Change0.28%
Analyst Ratings
DateActionAnalystRatingTarget
Oct-30-24ReiteratedStifel NicolausHold$28 → $20
Jul-25-23DowngradeKeybancOverweight → Sector Weight
Jan-06-23ReiteratedMorgan StanleyUnderweight$28 → $26
Jul-18-22ReiteratedStifel NicolausHold$28
Jul-15-22ReiteratedMorgan StanleyUnderweight$33 → $28
May-05-22ReiteratedMorgan StanleyUnderweight$33
Aug-04-21DowngradeStephens & Co.Overweight → Equal Weight
Apr-13-20UpgradeBarclaysUnderweight → Equal Weight
Nov-07-19DowngradeStifelBuy → Hold
Nov-07-19DowngradeStifel NicolausBuy → Hold
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue716701688
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A369352307
Gross Profit347349381
Selling, General and Administrative Excl. Other290218315
Research and Development232326
Other Operating Expense911700
Operating Income-57-6240
Interest Expense8412
Unusual Expense
———
Non-Operating Income (Expense)51431
Net Income Before Taxes-68-66-403
Income Taxes22-17
Consolidated Net Income-69-68-392
Net Income From Continuing Operations-69-68-386
Net Income-69-68-392
EPS (Recurring)-1.50-1.46-8.53
EPS (Basic, Before Extraordinaries)-1.50-1.46-8.53
EPS (Diluted)-1.50-1.46-8.53
EBITDA-22-33-346
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio1.600.74—
Gross Margin48.4649.7955.38
Operating Margin-7.96-8.845.81
Net Margin-9.64-9.70-56.98
Shares Outstanding464646
Market Capitalization1,147517—
Operating Lease Expense
———
Insider Trading Volume
$28.89$25.66$22.43$19.20$15.97● Close Price0.00K164.82K329.65K494.48K659.30KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Hurley John JosephPrincipal Accounting OfficerMar 06 '26Option Exercise13.7991912,67312,283Mar 10 12:00 AM
Galovan Scott MichaelSVP, Chief Financial OfficerMar 06 '26Option Exercise13.795,90781,458116,916Mar 10 12:00 AM
Holbrook KerrSVP, Chief Commercial OfficerNov 18 '25Sale11.0015,000165,01583,860Nov 19 12:00 AM
BLACKFORD GARYDirectorAug 13 '25Buy10.9960,000659,30091,593Aug 15 12:00 AM
Holbrook KerrSVP, Chief Commercial OfficerMar 06 '25Sale15.257,000106,77882,047Mar 10 12:00 AM
James MojiradeSVP, General CounselMar 04 '25Option Exercise0.008,039078,352Mar 06 12:00 AM
Woody Joseph Fralinother: Former Chief Executive OfficerMar 04 '25Option Exercise0.0032,1580453,203Mar 06 12:00 AM
Holbrook KerrSVP, Chief Commercial OfficerMar 04 '25Option Exercise0.005,145092,393Mar 06 12:00 AM
Hurley John JosephPrincipal Accounting OfficerMar 04 '25Option Exercise0.00107010,172Mar 06 12:00 AM
Greiner MichaelInterim CEOMar 04 '25Option Exercise0.0012,1490214,235Mar 06 12:00 AM
Greiner MichaelSVP - Chief Financial OfficerMar 18 '24Option Exercise0.004,2190155,714Mar 19 12:00 AM
Holbrook KerrSVP, Chief Commercial OfficerMar 18 '24Option Exercise0.002,531089,727Mar 19 12:00 AM
Woody Joseph FralinChief Executive OfficerMar 18 '24Option Exercise0.0015,8210453,810Mar 19 12:00 AM
Greiner MichaelSVP - Chief Financial OfficerMar 14 '24Sale19.128,000152,980151,495Mar 15 12:00 AM
Shimer Julie AnnDirectorMar 11 '24Buy19.855009,92550,090Mar 11 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR